The 17th St. Gallen International Breast Cancer Conference was held virtually this year due to the ongoing COVID-19 pandemic. Although the meeting was virtual, the programme was full of the latest data, ongoing controversies in the field, and updates on potential new treatments for breast cancer, culminating in the renowned St Gallen International Consensus on the Optimal Primary Treatment of Women with Breast Cancer 2021.

View all videos

BCC 2021

17th St. Gallen International Breast Cancer Conference
17–21 March 2021 | Virtual Meeting

longer follow up (3 years) continues to show ctDNA is strongly associated with relapse (HR=6) and a 40% ⬇️ risk of death with atezo in adjuvant UC. There’s a strong rationale for circulating rather than tissue biomarkers here. Imvigor011 (randomised III) tests this prospectively

4

Last day at #EAU22, Outstanding plenary session and inspiring presentations on liquid biomarkers in #RCC
@AStenzl @grantissimus @TurajlicLab @ZeynepZengin @srossi725
@EAUYAU_RenalCa @Uroweb @AmerUrological @KidneyCancer

4

💥 It’s the final day of #EAU22! 💥

The last day is packed with more fantastic speakers, so don’t miss out! Head to http://VJOncology.com for all updates on EAU 2022 so far!

@Uroweb #PCSM #Blcsm #kcsm #uroonc

What a force @ZeynepZengin is! So proud of her for delivering such a fantastic talk about the role of liquid biopsies in guiding treatment selection in RCC. Learning from the best, of course! @montypal #EAU22 #RCC

2
Load More

BCC 2021

17th St. Gallen International Breast Cancer Conference
17–21 March 2021 | Virtual Meeting

The 17th St. Gallen International Breast Cancer Conference was held virtually this year due to the ongoing COVID-19 pandemic. Although the meeting was virtual, the programme was full of the latest data, ongoing controversies in the field, and updates on potential new treatments for breast cancer, culminating in the renowned St Gallen International Consensus on the Optimal Primary Treatment of Women with Breast Cancer 2021.

View all videos

longer follow up (3 years) continues to show ctDNA is strongly associated with relapse (HR=6) and a 40% ⬇️ risk of death with atezo in adjuvant UC. There’s a strong rationale for circulating rather than tissue biomarkers here. Imvigor011 (randomised III) tests this prospectively

4

Last day at #EAU22, Outstanding plenary session and inspiring presentations on liquid biomarkers in #RCC
@AStenzl @grantissimus @TurajlicLab @ZeynepZengin @srossi725
@EAUYAU_RenalCa @Uroweb @AmerUrological @KidneyCancer

4

💥 It’s the final day of #EAU22! 💥

The last day is packed with more fantastic speakers, so don’t miss out! Head to http://VJOncology.com for all updates on EAU 2022 so far!

@Uroweb #PCSM #Blcsm #kcsm #uroonc

What a force @ZeynepZengin is! So proud of her for delivering such a fantastic talk about the role of liquid biopsies in guiding treatment selection in RCC. Learning from the best, of course! @montypal #EAU22 #RCC

2
Load More

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter